Michael F. Beers, MD

Professor of Medicine
 mfbeers@pennmedicine.upenn.edu
 215-898-9106

@WestPhillyTough

Pulmonary, Allergy & Critical Care Division
Edward J Stemmler Hall –Suite 216
3450 Hamilton Walk
Philadelphia, PA 19104

Education and Training

• MD: University of Pennsylvania
• Residency: Hospital of the University of Pennsylvania
• Pulmonary and Critical Care Fellowship: University of Pennsylvania
• Post-Doctoral Research Fellowship: Institute for Environmental Medicine, Philadelphia PA

Bio

Michael Beers has pursued an academic career centered in basic research of lung epithelial cell biology and surfactant protein metabolism.  He currently holds a joint appointment as Professor of Medicine in the Pulmonary, Allergy, and Critical Care Division and Senior Investigator at the PENN Lung Biology Institute at the Perelman School of Medicine of the University of Pennsylvania.

As a native Philadelphian and graduate of the Faculty of Arts and Sciences of the University of Pennsylvania, Dr. Beers completed Medical School at the University of Pennsylvania in 1985.  His post-graduate training has included an Internship and Residency in Internal Medicine, and Fellowship in Pulmonary and Critical Care at the Hospital of the University of Pennsylvania.  Dr. Beers trained as a postdoctoral research fellow in the laboratory of Dr. Aron Fisher at the Institute for Environmental Medicine at PENN and joined the faculty at PENN in 1993.

Dr Beers serves as Group Leader for the following active projects:

• Epithelial Dysfunction and Parenchymal Lung Disease. We are using novel mouse models of pulmonary fibrosis to characterize the mechanisms underlying the development of the cellular dysfunction driving the cascade of inflammatory and aberrant remodeling events leading to pulmonary fibrosis in vivo. Current projects focus on metabolic reprogramming, AT2-mesenchyme cross talk, roles for treg and monocyte/macrophase lineages, ER stress, and identification of new pulmonary fibrosis targets using 'omics' approaches. 
• Biosynthetic Pathways for SP-C: The cellular metabolism of surfactant protein C with emphasis on the intracellular trafficking of SP-C and the cellular quality control pathways of AT2 cells.
• Innate Immunity and Inflammation- The role of pulmonary collectins (surfactant proteins A and D) in the modulation of inflammation and injury.

Dr Beers serves as Co-Director of the NIH T32 training grant for post-doctoral research in the Pulmonary and Critical Care Division. If you are interested in post-doctoral fellowship training, contact Dr. Beers via e-mail.